Clinical Factor | Survived, N = 546, n (%) | Died, N = 34, n (%) | Unadjusted OR (95% CI) | p-value | Adjusted ORb (95% CI) | p-value |
---|---|---|---|---|---|---|
Male sex | 321 (59) | 23 (68) | 1.5 (0.7–3.4) | 0.37 | – | – |
Child < 12 years | 267 (49) | 11 (32) | 0.5 (0.2–1.1) | 0.08 | 0.2 (0.1–0.4) | < 0.01 |
Income < 5000 INR / month | 197 (36) | 15 (44) | 1.4 (0.6–3) | 0.36 | – | – |
Diabetes | 18 (3) | 1 (3) | 0.9 (0–6) | 1 | – | – |
HIV | 56 (10) | 7 (21) | 2 (0.6–5.7) | 0.17 | – | – |
Diarrhea | 110 (20) | 9 (26) | 1.4 (0.6–3.3) | 0.38 | – | – |
Cough | 278 (51) | 13 (38) | 0.6 (0.3–1.3) | 0.16 | – | – |
ICU admission | 96 (18) | 19 (56) | 6.8 (3.1–15.6) | < .01 | 14.7 (6.1–36.9) | < 0.01 |
Admission ceftriaxone-resistant EB colonization | 52 (10) | 2 (6) | 0.6 (0.1–2.4) | 0.76 | – | – |
Follow-up ceftriaxone-resistant EB colonization | 53 (10) | 8 (24) | 2.9 (1.1–6.9) | 0.02 | 2.4 (0.9–6.0) | 0.06 |
Acquisition of ceftriaxone-resistant EB colonization | 37 (7) | 6 (18) | 2.8 (0.9–7.7) | 0.04 | – | – |